Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuyan Granules is a Traditional Chinese Medicine (TCM) preparation developed by the Institute of Chinese Materia Medica at the China Academy of Chinese Medical Sciences (CACMS). It is primarily indicated for the treatment of acute pharyngitis, a condition characterized by inflammation of the pharyngeal mucosa, sore throat, and congestion. The formulation is based on TCM principles of clearing heat and detoxifying, incorporating herbal ingredients such as *Radix Isatidis* (Ban Lan Gen) and *Radix Scutellariae* (Huang Qin). Pharmacological studies indicate that Shuyan Granules possesses anti-inflammatory, analgesic, and antibacterial properties, effectively reducing pharyngeal swelling and alleviating pain. It is approved and marketed in China as a standard treatment for throat-related inflammatory conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shuyan Granules.